Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NSDHL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPEL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ARHGAP18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BLVRB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PFDN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EEF1D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNHIT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIMD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDCD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS18A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPECC1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF113A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFB7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BLVRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100630923 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NQO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFDP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on